Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer

Context: In advanced prostate cancer (PC), there is increasing investigation of circulating biomarkers, including quantitation and characterization of circulating tumour cells and cell-free nucleic acids, for therapeutic monitoring and as prognostic and predictive biomarkers. However, there is a lack of consensus and standardisation regarding analyses, reporting, and integration of results into specific clinical contexts. A consensus meeting on circulating biomarkers was held to address these topics. Objective: To present a report of the consensus statement on circulating biomarkers in advanced PC. Evidence acquisition: Four important areas of controversy in the field of circulating biomarkers in PC management were identified: known clinical utility of circulating biomarkers; unmet clinical needs for circulating biomarkers in PC care; most pressing blood-based molecular assays required; and essential steps for developing circulating biomarker assays. A panel of 18 international PC experts in the field of circulating biomarkers developed the programme and consensus questions. The panel voted publicly but anonymously on 50 predefined questions developed following a modified Delphi process. Evidence synthesis: Voting was based solely on panellist opinions of the predefined topics and therefore not on a standard literature review or meta-analysis. The outcomes of the voting had varying degrees of support, as reflected in the wording of this article and in the detailed voting results provided in the Supplementary material. Conclusions: The expert voting results presented can guide the future development of circulating biomarkers for PC care. Notably, the consensus meeting highlighted the importance of reproducibility and variability studies, among other significant areas in need of trials specifically designed to address them. Patient summary: A panel of international experts met to discuss and vote on the use of different blood-based prostate cancer tests, and how they can be used to guide treatment and disease monitoring to deliver more precise and better patient car

Recent volcanic accretion at 9 degrees N-10 degrees N East Pacific Rise as resolved by combined geochemical and geological observations

The ridge crest at 9°N-10°N East Pacific Rise (EPR) is dominated by overlapping lava flows that have overflowed the axial summit trough and flowed off-axis, forming a shingle-patterned terrain up to ∼2-4 km on either side of the axial summit trough. In this study, we employ 230Th- 226Ra dating methods, in conjunction with geochemistry and seafloor geological observations, in an effort to discern the stratigraphic relationships between adjacent flows. We measured major and trace elements and 87Sr/86Sr, 143Nd/144Nd, 176Hf/177Hf, and 238U-230Th- 226Ra for lava glass samples collected from several flow units up to ∼2 km away from the axial summit trough on the ridge crest at 9°50′N EPR. Statistical analysis of the 238U- 230Th-226Ra data indicates that all but one measured sample from these flows cannot be resolved from the zero-age population; thus, we cannot confidently assign model ages to samples for discerning stratigraphic relationships among flows. However, because groups of samples can be distinguished based on similarities in geochemical compositions, particularly incompatible element abundances with high precision-normalized variability such as U and Th, and because the range of compositions is much greater than that represented by samples from the 1991-1992 and 2005-2006 eruptions, we suggest that the dive samples represent 6-10 eruptive units despite indistinguishable model ages. Geochemical variability between individual flows with similar ages requires relatively rapid changes in parental melt composition over the past ∼2 ka, and this likely reflects variations in the relative mixing proportions of depleted and enriched melts derived from a heterogeneous mantle source. ©2013. American Geophysical Union. All Rights Reserved